Vaxcyte, Inc. (PCVX) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $3.00B | -14.5% |
| 2024 | $3.51B | +149.4% |
| 2023 | $1.41B | +39.9% |
| 2022 | $1.01B | +210.2% |
| 2021 | $324.34M | -17.4% |
| 2020 | $392.83M | +497.9% |
| 2019 | $65.70M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $3.00B | -14.5% |
| 2024 | $3.51B | +149.4% |
| 2023 | $1.41B | +39.9% |
| 2022 | $1.01B | +210.2% |
| 2021 | $324.34M | -17.4% |
| 2020 | $392.83M | +497.9% |
| 2019 | $65.70M | — |